Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

News > All

Please find below news from the Benelux countries (Belgium, Luxembourg and The Netherlands) as well as about organisations from these countries.

Total search results: 2630 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
iTeos Therapeutics S.A.. (4/1/20). "Press Release: iTeos Therapeutics Closes $125 Million Series B2 Financing". Cambridge, MA & Gosselies. 2020-04-01
Gilde Healthcare Partners. (3/31/20). "Press Release: Gilde Healthcare Raises €416 million ($450 million) Venture and Growth Capital Fund". Utrecht & Cambridge, MA. 2020-03-31
AM-Pharma B.V.. (3/31/20). "Press Release: AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI". Utrecht. 2020-03-31
InflaRx N.V.. (3/31/20). "Press Release: InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology". Jena. 2020-03-31
Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies. 2020-03-26
Medigene AG. (3/26/20). "Press Release: Medigene Provides Results for Fiscal Year 2019 and Outlook". Martinsried. 2020-03-26
Qiagen N.V.. (3/24/20). "Press Release: Qiagen Names Thierry Bernard as Chief Executive Officer". Venlo, Hilden & Germantown, MD. 2020-03-24
Immatics Biotechnologies GmbH. (3/17/20). "Press Release: Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies". Houston, TX & Tübingen. 2020-03-17
Affimed N.V.. (3/17/20). "Press Release: Affimed Announces Appointment of Arndt Schottelius, M.D. Ph.D. as Chief Scientific Officer". Heidelberg. 2020-03-17
Life Sciences Partners (LSP). (3/10/20). "Press Release: LSP Closes Largest Ever European Life Sciences Fund at $600 Million". Amsterdam, Munich & Boston, MA. 2020-03-10
UCB S.A.. (3/9/20). "Press Release: UCB Announces Appointment of Sandrine Dufour as New Chief Financial Officer". Brussels. 2020-03-09
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces 2019 Results and 2020 Outlook". Mechelen. 2020-03-05
Orionis Biosciences. (3/5/20). "Press Release: Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets". Boston, MA & Ghent. 2020-03-05
Biotalys N.V.. (3/5/20). "Press Release: Biotalys Announces Second Closing of €45 Million Series C Financing Round". Ghent. 2020-03-05
Biocartis Group N.V.. (3/5/20). "Press Release: Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla MSI test in China". Mechelen. 2020-03-05
Qiagen N.V.. (3/3/20). "Press Release: Conclusion of a Business Combination Agreement between Qiagen N.V. and Thermo Fisher Scientific Inc., Announcement of a Public Tender Offer by Thermo Fisher Scientific Inc. [Ad hoc]". Venlo. 2020-03-03
Qiagen N.V.. (3/3/20). "Press Release: Thermo Fisher Scientific to Acquire Qiagen N.V.". Waltham, MA & Venlo. 2020-03-03
Uniqure N.V.. (3/2/20). "Press Release: Uniqure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters". Lexington, MA & Amsterdam. 2020-03-02
Uniqure N.V.. (3/2/20). "Press Release: Uniqure Announces 2019 Financial Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2020-03-02
iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies. 2020-02-27
DSM N.V.. (2/21/20). "Press Release: DSM to Acquire Glycom to Accelerate Growth in Early Life Nutrition". Heerlen. 2020-02-21
Adrenomed AG. (2/21/20). "Press Release: Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock". Hennigsdorf. 2020-02-21
Univercells S.A.. (2/18/20). "Press Release: Univercells Secures up to €50M Investment from KKR Platform to Speed Delivery of Manufacturing Technologies". Brussels. 2020-02-18
OncoDNA S.A.. (2/14/20). "Press Release: OncoDNA Closes Successful Series B Investment Round". Gosselies. 2020-02-14
Azafaros B.V.. (2/6/20). "Press Release: Azafaros Completes EUR 25 Million Series A Financing to Advance Rare Metabolic Disorders Pipeline". Leiden. 2020-02-06
Gilead Sciences, Inc.. (2/4/20). "Press Release: Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results". Foster City, CA. 2020-02-04
Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ. 2020-02-03
Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. 2020-02-03
Catalent, Inc.. (2/3/20). "Press Release: Catalent to Acquire Leading Cell Therapy Company MaSTherCell Global for $315 Million, Creating an Industry-Leading Cell & Gene Therapy Platform". Somers, NJ & Gosselies. 2020-02-03
iTeos Therapeutics S.A.. (1/30/20). "Press Release: iTeos Therapeutics Awarded €15 Million in Non-Dilutive Funding by the Walloon Region". Gosselies & Cambridge, MA. 2020-01-30
Biocartis Group N.V.. (1/27/20). "Press Release: Biocartis Announces Resignation of CFO". Mechelen. 2020-01-27
C4Diagnostics S.A.S.. (1/24/20). "Press Release: C4Diagnostics Raises € 2.3 Million in Series A and Brings a US Investor to the Founding Round, to Accelerate the Deployment of Its Infectious Diseases’ Diagnostic Solutions". 2020-01-24
iOnctura B.V.. (1/23/20). "Press Release: iOnctura Raises EUR 15 Million in Series A Financing to Progress Its Pipeline into Clinical Development". Amsterdam. 2020-01-23
Galapagos N.V.. (1/23/20). "Press Release: Galapagos Appoints Michele Manto as Chief Commercial Officer". Mechelen. 2020-01-23
PDC*line Pharma S.A.. (1/22/20). "Press Release: PDC*line Pharma Raises €20 million in Series B Financing Round". Liège & Grenoble. 2020-01-22
BlueRock Therapeutics. (1/21/20). "Press Release: Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes". Leiden & Cambridge, MA. 2020-01-21
Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. 2020-01-20
Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. 2020-01-16
Galapagos N.V.. (1/15/20). "Press Release: Fibrocor and Galapagos Sign Expanded Collaboration in Fibrosis". Mechelen & Toronto. 2020-01-15
ProBioGen AG. (1/14/20). "Press Release: ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule". Berlin & Utrecht. 2020-01-14
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA. 2020-01-14
Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. 2020-01-13
Galapagos N.V.. (1/13/20). "Press Release: Galapagos Completes Recruitment of PINTA Trial in Idiopathic Pulmonary Fibrosis". Mechelen. 2020-01-13
NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. 2020-01-10
Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. 2020-01-10
Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. 2020-01-08
NorthSea Therapeutics B.V.. (1/8/20). "Press Release: NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA Study in NASH and to Advance Two Additional SEFAs into the Clinic". Naarden. 2020-01-08
CureVac AG. (1/7/20). "Press Release: CureVac Announces Positive Results in Low Dose – 1 µg – Rabies Vaccine Clinical Phase 1 Study". Tübingen & Boston, MA. 2020-01-07
Galecto Biotech AB. (1/7/20). "Press Release: Galecto and PharmAkea Merge to Create Strong Clinical-stage Company Developing First-in-Class Therapeutics in Fibrosis and Cancer". San Diego, CA & Copenhagen. 2020-01-07
Bone Therapeutics S.A.. (12/19/19). "Press Release: Bone Therapeutics Announces the Appointment of Dr. Miguel Forte as CEO to Lead the Company into the Next Phase of Development". Gosselies. 2019-12-19
Cellestia Biotech AG. (12/17/19). "Press Release: Successful Closing of Series B Financing Round with CHF 20M". Basel. 2019-12-17
Augustine Therapeutics. (12/16/19). "Press Release: VIB and KU Leuven Announce New Spin-off Augustine Therapeutics to Fight Neuromuscular Diseases". Belgium. 2019-12-16
Promethera Biosciences S.A.. (12/16/19). "Press Release: Promethera Attracts Sony Innovation Fund by IGV and Pegasus Tech Ventures as New Investors in Final Closing of Series D . Total Amount Raise in the Series D Reaches €47.2 Million". Mont-Saint-Guibe 2019-12-16
Sphingotec GmbH. (12/16/19). "Press Release: Sphingotec’s Proprietary Biomarker bio-ADM Detects Residual Congestion in Patients with Heart Failure". Hennigsdorf. 2019-12-16
iTeos Therapeutics S.A.. (12/12/19). "Press Release: iTeos Therapeutics Announces Collaboration with Merck Investigating the Combination of its A2A Antagonist with Keytruda". Gosselies & Cambridge, MA. 2019-12-12
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. 2019-12-10
Biotalys N.V.. (12/10/19). "Press Release: AgroSavfe Announces Name Change to Biotalys and Incorporation of US Subsidiary, Biotalys, Inc.". Ghent. 2019-12-10
ImCheck Therapeutics S.A.S.. (12/4/19). "Press Release: ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases". Marseille. 2019-12-04
Kuros Biosciences Ltd.. (12/3/19). "Press Release: Kuros Announces Final Result of Capital Increase – Total Gross Proceeds of CHF 12.5 Million Raised [Not for US, UK, AU, et al.]". Schlieren. 2019-12-03
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. 2019-12-02
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". 2019-11-29
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. 2019-11-28
Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. 2019-11-27
Qiagen N.V.. (11/20/19). "Press Release: Qiagen and LabCorp Deepen Relationship with Widespread Use of Bioinformatics Solutions". Hilden & Germantown, MD. 2019-11-20
Coulter Partners. (11/20/19). "Press Release: Coulter Partners Opens Brussels Office and Makes Six Strategic Appointments". 2019-11-20
Sangamo Therapeutics, Inc.. (11/19/19). "Press Release: Sangamo Announces UK Authorization of a Phase 1/2 Clinical Trial Evaluating the CAR-Treg Cell Therapy TX200 for Kidney Transplantation". Brisbane, CA. 2019-11-19
Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. 2019-11-19
Qiagen N.V.. (11/15/19). "Press Release: Qiagen Receives Several Conditional, Non-binding Indications of Interest, Enters into Discussions to Explore Potential Strategic Alternatives". Venlo. 2019-11-15
Kiadis Pharma N.V.. (11/12/19). "Press Release: Kiadis Pharma Changes Strategy to Focus Solely on Development of Natural Killer (NK) Cell Therapeutics and Terminates Development of ATIR101". Amsterdam. 2019-11-12
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
Argenx SE. (11/8/19). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda & Ghent. 2019-11-08
Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. 2019-11-07
Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. 2019-11-07
Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. 2019-11-06
Acticor Biotech S.A.S.. (11/6/19). "Press Release: Acticor Biotech Raises €7m in Addition to Its Series B Financing, Now Completed at €22.3m". Paris. 2019-11-06
Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. 2019-10-29
Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. 2019-10-28
OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. 2019-10-28
Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. 2019-10-28
Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. 2019-10-28
MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. 2019-10-28
Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. 2019-10-28
Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. 2019-10-25
Galapagos N.V.. (10/24/19). "Press Release: Solid Third Quarter 2019 Performance with Strong Balance Sheet for Continued R&D Growth". Mechelen. 2019-10-24
OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. 2019-10-23
Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. 2019-10-22
Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. 2019-10-22
Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. 2019-10-22
Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. 2019-10-17
Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam. 2019-10-17
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Gilead Sciences, Inc.. (10/15/19). "Press Release: Gilead Sciences Appoints Andrew Dickinson as Chief Financial Officer". Foster City, CA. 2019-10-15
Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen. 2019-10-10
UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. 2019-10-10
N-Side S.A.. (10/9/19). "Press Release: N-Side Welcomes Wade Wirta as US Managing Director". Louvain-la-Neuve. 2019-10-09
Bluebee. (10/9/19). "Press Release: BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for its Genomics Data Platform". Rijskwijk. 2019-10-09
Illumina, Inc.. (10/7/19). "Press Release: Illumina and Qiagen Partner to Deliver Sequencing-Based In-Vitro Diagnostic (IVD) Tests". San Diego, CA & Hilden & Germantown, MD. 2019-10-07
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Reports Preliminary Q3 2019 Results and Announces Measures to Prioritize Resource Allocation". Venlo. 2019-10-07
Qiagen N.V.. (10/7/19). "Press Release: Qiagen Announces CEO Leadership Transition. Peer M. Schatz to Step Down as CEO to Pursue New Opportunities". Venlo. 2019-10-07
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top